Trials / Conditions / Epidermolysis Bullosa (EB)

Epidermolysis Bullosa (EB)

9 registered clinical trials studyying Epidermolysis Bullosa (EB) — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis Bullosa NCT07482813	Paradigm Therapeutics	Phase 3
Not Yet Recruiting	Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa NCT07482787	Paradigm Therapeutics	Phase 3
Not Yet Recruiting	Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications NCT07240649	Jay C. Buckey Jr.	Phase 4
Recruiting	A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study NCT06594393	Xinnate AB	Phase 2
Not Yet Recruiting	Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) NCT07011589	M. Peter Marinkovich	Phase 1 / Phase 2
Recruiting	Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft® Duo With De NCT07312513	Lohmann & Rauscher	N/A
Active Not Recruiting	Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa NCT06713434	Fundación DEBRA Chile, Niños Piel de Cristal	Phase 1
Suspended	A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease NCT04031469	ProgenaBiome	—
Completed	To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullos NCT03472287	Castle Creek Pharmaceuticals, LLC	Phase 1